Diagnostics
Pantalis 40 Injection delivers fast and effective relief for patients suffering from acid reflux, GERD (Gastroesophageal Reflux Disease), and other upper gastrointestinal disorders. Formulated with Pantoprazole 40 mg, it works by reducing stomach acid production, promoting rapid symptom relief, and enabling mucosal healing. It is highly effective in the treatment of NSAID-induced gastritis, functional dyspepsia, non-ulcer dyspepsia, and erosive esophagitis.
Backed by clinical data, Pantalis 40 shows a 72.34% success rate in healing erosive GERD, along with high symptom improvement rates. Its lyophilized form ensures stability and precise dosing for intravenous administration. Recommended for hospital use and acute care settings, Pantalis 40 is a safe, trusted, and scientifically advanced solution that restores comfort and improves quality of life for patients with gastrointestinal distress.
Research & Clinical Data for Pantalis 40
Active Ingredient
Pantoprazole Sodium 40 mg (Lyophilized Powder for Injection)
Proton Pump Inhibitor (PPI) – selectively inhibits the H+/K+ ATPase enzyme in gastric parietal cells, effectively reducing gastric acid secretion./p>
- Onset: Rapid plasma concentration peak in 30–60 minutes
- Half-life: ~1 hour
- No significant accumulation on repeated dosing
- Extensively metabolized in the liver via CYP2C19 and CYP3A4 pathways
Indications Supported by Evidence
- NSAIDs-Induced Gastritis: Demonstrated reduction in gastric mucosal inflammation and pain severity.
- Functional & Non-Ulcer Dyspepsia: Improved gastric emptying time and reduced bloating and epigastric discomfort.
- Erosive Esophagitis: Shown to accelerate epithelial healing and reduce recurrence.
Dosage & Administration
Pantalis 40 is administered via slow IV injection or infusion once daily.
Recommended for short-term use in acute care settings or when oral administration is not feasible.
Dosage & Administration
Recommended for short-term use in acute care settings or when oral administration is not feasible.
Indication:
NSAIDs Induced Gastritis
Functional Dyspepsia
Non-ulcer Dyspepsia
Erosive Esophagitis
Frequently asked question
Pantalis 40 is used to treat acid reflux, GERD, erosive esophagitis, NSAID-induced gastritis, and various forms of dyspepsia. It helps reduce stomach acid and promote healing of the gastrointestinal lining.
It contains Pantoprazole, a proton pump inhibitor (PPI), which blocks acid production in the stomach by inhibiting the H+/K+ ATPase enzyme in gastric parietal cells.
Pantalis 40 is given as a slow intravenous injection or infusion, typically once a day. It is intended for short-term use in hospital or clinical settings.
Many patients experience significant symptom relief within 24–48 hours after the first dose. Healing of erosive conditions typically occurs within 7–10 days.
Pantalis 40 is generally recommended for short-term use via injection. For long-term acid suppression, oral formulations of Pantoprazole may be prescribed under medical guidance.